(PharmaNewsWire.Com, June 13, 2020 ) The growth of this market is primarily driven by the rising incidence of chronic diseases, growing importance of generics, rising adoption of track & trace solutions, and the growth of the medical device industry.In addition, emerging markets such as China and...
(PharmaNewsWire.Com, June 13, 2020 ) Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological...
(PharmaNewsWire.Com, June 13, 2020 ) Significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely...
(PharmaNewsWire.Com, June 13, 2020 ) Factors such as the increasing geriatric population, a growing number of surgical procedures, a high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are expected to...
(PharmaNewsWire.Com, June 13, 2020 ) The Vascular Graft Market is expected to reach USD 5.40 billion by 2027 from USD 2.67 billion in 2017, at a CAGR of 7.3%. Factors driving the growth of this market include in the aging population and the associated increase in the prevalence of aneurysms, rise...
(PharmaNewsWire.Com, June 13, 2020 ) The veterinary diagnostics market is expected to reach USD 4.00 billion by 2023 from an estimated USD 2.63 billion in 2018, at a CAGR of 8.8 %. Factors such as growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for...
(PharmaNewsWire.Com, June 13, 2020 ) The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.The demand for transplant diagnostic products is expected to grow mainly due to factors such as technological advancements, the growing...
(PharmaNewsWire.Com, June 13, 2020 ) Factors such as the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research are responsible for the large share of the market. However, factors such as the high cost...
(PharmaNewsWire.Com, June 13, 2020 ) The global laboratory LIMS market is expected to reach USD 1,355.0 million by 2023 from USD 747.3 million in 2018, at a CAGR of 12.6%. Growth in this market is driven by the increasing use of LIMS to comply with stringent regulatory requirements, increasing focus...
(PharmaNewsWire.Com, June 15, 2020 ) The growth of neuromodulation market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation...
(PharmaNewsWire.Com, June 13, 2020 ) According to United Nations Department of Economic and Social Affairs, the global percentage share of the aging population (aged 60 years or above) has increased from 9.2% in 1990 to 11.7% in 2013, and is anticipated to reach 21.1% by 2050. Aging heightens the...
(PharmaNewsWire.Com, June 15, 2020 ) The major factors driving the growth of diagnostic imaging services market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening...
(PharmaNewsWire.Com, June 15, 2020 ) The growing prevalence of neurological diseases, efforts to develop the application base for neuromodulation, and the benefits of neuroendoscopic surgeries over conventional brain surgeries are driving the growth of the neurosurgery devices market.The neurosurgery...
(PharmaNewsWire.Com, June 15, 2020 ) The adoption of microsurgical instruments is growing across major regions majorly due to the benefits of microsurgeries over traditional surgeries; the increasing number of surgeries among the geriatric population & growing popularity of plastic and reconstructive...
(PharmaNewsWire.Com, June 13, 2020 ) The live cell imaging market in the region is driven by the availability of government funding for life science research, drug development regulations, advances in live cell imaging techniques, growth in the biotechnology and pharmaceutical industries, and the...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
